Lanxess Opens LFP Battery Lab at Krefeld-Uerdingen Site

Specialty chemicals maker Lanxess has commissioned a new battery laboratory at its Krefeld-Uerdingen site in Germany, where it will test and further develop its materials for lithium iron phosphate (LFP) batteries directly inside battery cells.

Lanxess has commissioned a new battery laboratory at its Krefeld-Uerdingen site in Germany, giving the specialty chemicals group a place to test and further develop its materials for lithium iron phosphate batteries inside actual battery cells rather than only in the beaker.

That last detail is the whole point of the facility. A chemicals company can characterise a powder endlessly — particle size, purity, surface area, tap density — and still not know how it behaves after several hundred charge cycles in a cell built by a customer. Building and cycling cells in-house closes that gap, and it changes the conversation a supplier can have with a cell maker.

Why testing in a cell, not a beaker, matters

LFP — lithium iron phosphate — is the cathode chemistry that has taken over the low- and mid-priced end of the electric vehicle market and most of the stationary storage market. It gives up energy density relative to nickel-rich chemistries but wins on cost, cycle life and thermal behaviour, and it uses no cobalt and no nickel. The cathode is built from a lithium source and an iron phosphate precursor, and iron oxide chemistry sits upstream of that precursor.

For a supplier of upstream materials, the commercial problem is qualification. Cell manufacturers do not swap material inputs casually; a new precursor has to be proven across cycling, rate capability, calendar life and safety testing before it goes anywhere near a production line, and that process can run for a long time. A supplier that can present cell-level data at the first meeting shortens the loop. That is the practical argument for the Krefeld-Uerdingen laboratory, as reported by electrive.

It also gives Lanxess a feedback channel in the other direction. If a cell built with its material underperforms at high rates, the laboratory can point back at a specific attribute of the powder and the process that made it — something a customer's rejection email rarely does in useful detail.

Europe's cathode supply chain problem

The strategic backdrop is straightforward and uncomfortable for European industry. LFP cathode active material production is overwhelmingly concentrated in Asia, and Europe's cell plants — the ones that have been built, and the ones still being planned — largely import their cathode powder. Every stage upstream of the cell that Europe does not make domestically is a stage exposed to freight, tariffs, export licensing and single-country concentration.

Localising that chain is not a matter of one decision. It requires, in rough order: iron and phosphate feedstock, precursor conversion, cathode active material synthesis, then the cell itself. Each step is capital-hungry and each needs a customer signed up before the capital is committed. A laboratory is the cheap end of that ladder — but it is the step that makes the expensive ones bankable, because it produces the evidence a future offtake partner will demand.

Krefeld-Uerdingen is a logical place to do it. It is a long-established chemicals site with existing infrastructure, utilities and permitting, which is a meaningful advantage in Germany, where greenfield industrial approval is slow and energy costs have been a persistent complaint from the chemicals sector.

What the move signals about specialty chemicals and batteries

European specialty chemicals companies have spent recent years looking for growth pockets that are not tied to construction, automotive coatings or general industrial demand. Battery materials is one of the few genuinely expanding end markets available to them, and it plays to an existing competence: inorganic chemistry at scale, with tight control of impurities.

The catch is that battery materials is also a market where Chinese producers have established very low cost positions and where price, not novelty, decides orders. A European entrant cannot win on cost alone. It has to offer something else — regional supply security, a carbon footprint that helps a customer meet regulatory thresholds, or performance consistency that reduces a cell maker's scrap rate. Cell-level validation data is how a supplier substantiates the third of those claims.

Note what the announcement does not include: no production capacity figure, no investment total, no named customer and no commercial timeline have been attached to it. That is normal at this stage of a materials programme, and it is also the reason to treat the laboratory as a signal of intent rather than as a supply commitment.

The market frame around it

The news lands in a broadly flat equity tape. At the most recent close, on Friday 4 September 2026, the S&P 500 tracker SPY finished at $770.23, down 0.38% on the day from a previous close of $773.17. The Nasdaq 100 proxy QQQ closed at $719.00, up 0.19%, while the Dow tracker DIA ended at $534.12, down 0.52%. None of those moves reflect anything about battery materials specifically; they set the risk backdrop against which industrial capital spending decisions are being weighed.

That backdrop matters more than it might appear. Cathode projects in Europe have been repeatedly delayed or cancelled where the demand case softened or financing got more expensive. Laboratory-scale investment is deliberately small relative to a plant, and in a cautious capital environment it is exactly the kind of step a board approves while it waits for firmer demand signals from cell makers.

What to watch from here

• A named cell-maker partner. Qualification programmes usually surface publicly when a customer is willing to be identified. That is the first hard evidence the laboratory work is converting.
• A capacity announcement. Movement from laboratory to pilot line to commercial plant, with a stated tonnage, would mark the shift from research to supply.
• Where the iron and phosphate come from. A European precursor chain is only genuinely local if its feedstock is not itself imported from a single source.
• Policy support. European localisation rules, carbon-footprint requirements and any state aid for battery materials will shape whether a domestic supplier can price competitively against Asian incumbents.
• Storage demand. Grid-scale batteries have become a large LFP consumer in their own right, and that market's growth affects European precursor economics as much as EV volumes do.

For now, the concrete fact is a working laboratory at a functioning German chemicals site, aimed at proving out LFP materials in cells. Everything beyond that — tonnage, customers, plants — remains to be announced.

Key facts

• Facility: New battery laboratory at Lanxess's Krefeld-Uerdingen site, Germany
• Purpose: Test and further develop Lanxess materials for LFP batteries directly in battery cells
• Chemistry focus: Lithium iron phosphate (LFP) — cobalt- and nickel-free cathode
• Market backdrop (last close, 4 Sep 2026 20:00 GMT): SPY $770.23 (-0.38%); QQQ $719.00 (+0.19%); DIA $534.12 (-0.52%)

Frequently asked questions

What did Lanxess actually announce?

Lanxess, a specialty chemicals company, has commissioned a new battery laboratory at its Krefeld-Uerdingen site in Germany. The facility is intended to let the company test and further develop its materials for lithium iron phosphate batteries directly inside battery cells, rather than assessing the materials only in isolation as powders.

What is an LFP battery?

LFP stands for lithium iron phosphate, a cathode chemistry that contains no cobalt and no nickel. It stores less energy per kilogram than nickel-rich chemistries but is cheaper, lasts more charge cycles and behaves better thermally. It dominates entry- and mid-priced electric vehicles and most grid-scale stationary storage installations.

Why does testing materials inside cells matter?

Powder-level measurements such as purity and particle size do not reveal how a material performs after hundreds of charge cycles in a real cell. Cell-level data on cycling, rate capability and safety is what cell manufacturers require before qualifying a new supplier, so in-house cell testing shortens the qualification process considerably.

Does this mean Lanxess is building an LFP plant?

No. The announcement covers a laboratory only. No production capacity figure, investment total, named customer or commercial timeline has been attached to it. A laboratory is the low-cost step that generates the performance evidence needed before a company commits capital to a pilot line or a commercial-scale plant.

Why is Europe trying to localise LFP cathode production?

LFP cathode active material production is heavily concentrated in Asia, so European cell plants largely import their cathode powder. That leaves the chain exposed to freight costs, tariffs, export controls and single-country concentration. Building domestic precursor and cathode capability reduces that exposure, but requires capital at every stage upstream of the cell.

What are the main obstacles to a European LFP materials business?

Cost, principally. Chinese producers hold very low-cost positions and price largely decides orders in cathode materials. A European supplier has to compete on something else — regional supply security, a lower carbon footprint that helps customers meet regulatory thresholds, or performance consistency that cuts a cell maker's scrap rate.

Sources

• Lanxess commissions battery laboratory for LFP materials in Germany — electrive

Photo: Sergei Starostin · Pexels Licence — source